AzTrials
AzTrials

Preterm InfantSenSyNoPPNCT05399914

Feasibility and Reliability of Synchronized Non-invasive Intermittent Positive Pressure Ventilation in Preterm Infants After Birth

An observational study of Preterm Infant and Delivery Room, run by University Hospital Tuebingen at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this prospective observational study (pilot study) is to test if synchronized noninvasive positive pressure ventilation (S-NIPPV) is feasible and works appropriately during transition from intrauterine to extrauterine life in very preterm infants in the delivery room. Read more about this study

Who is it for?
Any age
Conditions the study is for
Preterm Infant, Delivery Room, Respiratory Support
What is being tested?
S-NIPPV
How many people
10 participants
Where
1 siteGermany
Study dates
22 Apr 2022to 11 Oct 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Child, Adult, Older adult

Study population: Preterm infants born at University Hospital in Tübingen.

Who may be able to join

  • Preterm infants with a gestational age (GA) between 26 ≥ and < 32 weeks

Who cannot join

  • Major congenital malformations
  • Refused parental consent (prenatal parental consent is necessary)

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University Hospital Tuebingen

    Tübingen, Baden-Wurttemberg, 72076

Other trials in Germany

About this study

The aim of this prospective observational study (pilot study) is to test if synchronized noninvasive positive pressure ventilation (S-NIPPV) is feasible and works appropriately during transition from intrauterine to extrauterine life in very preterm infants in the delivery room.

Read the detailed description

The study period will be the first 10 minutes after birth.

All patients will be non-invasively ventilated using an EVE NEO ventilator (CE 0482, Fritz Stephan GmbH, Gackenbach, Germany). A facemask will be used throughout the study period. Synchronization will be achieved using graseby capsule (Stephan, Vio Healthcare), which will be secured at the abdominal wall on the midaxillary line below the ribs. For the detection of spontaneous breaths respiratory induction plethysmography (RIP) is used. For this purpose, an extra small plethysmography belt (Sleepsense, Elgin, USA) is placed around the abdomen. The data of the plethysmography belts are processed and stored with the NewLifebox-XL (Advanced Life Diagnostics UG, Weener, Germany) and merged with the data from the ventilator for later evaluation.

Infants according to the clinician's assessment only needing CPAP will receive S-NIPPV with very low PIP levels. This enables to have enough ventilator breaths applied for analysis to obtain sufficient data about the synchronization rate of S-NIPPV in the delivery room and meanwhile consider the infant's safety by not applying high pressures where it might not be needed. The ventilator support settings will be PIP 10, PEEP 6 in the noninvasive pressure controlled assist control ventilation (nPC-ACV+) mode. In this mode every spontaneous breath is supported by a ventilator breath (if the triggering level is exceeded). The triggering level will be set at 0,5 to avoid autotriggering and unsupported breaths. The inspiratory time will be set at max. 0,3 sec. The backup ventilation rate is set at 60 per minute.The EVE NEO ventilator has in the nPC-ACV+ mode an option where the ventilator breaths are interrupted/stopped as soon as the graseby capsule detects a start of spontaneous expiration.

If the infant according to the clinician's assessment needs S-NIPPV (e.g. the infant is apnoeic, and/or heart rate is below 100 bpm), the pressure of S-NIPPV will be augmented to target PIP 20, PEEP 6 (unless clinical concerns require an adjustment). The respiratory support can be deescalated to PIP 10 once the clinician deems the higher pressure no longer necessary.

The following demographical characteristics will be collected from the patient charts (pseudonymized): gender, gestational age, birth weight, antenatal steroids, mode of delivery, reason for prematurity (prolong premature rupture of membrane, infection, pathologic CTG, pathological doppler, gestosis), time of cord clamping, umbilical cord pH, FiO2 requirement, APGAR.

The following interventions within the first 10 minutes after birth including the time will be noted: tactile stimulation, placement of an intravenous line, non-invasive surfactant administration, intubation, chest compression, administration of volume, catecholamine, blood or other medication.

Being tested
S-NIPPV
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • S-NIPPVOther

    Synchronized noninvasive positive pressure ventilation during the first 10 minutes after birth.

Study groups in NCT05399914
Study groupRoleWhat they receive
Preterm infants with a gestational age (GA) between 26 ≥ and < 32 weeksNot described
Receives: Other: S-NIPPV

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Synchronisation rate

    Synchronisation rate (sensitivity/true positive rate) of S-NIPPV in the delivery room meaning the proportion of graseby triggered synchronized ventilator breaths with corresponding RIP signal related to all spontaneous breaths detected by RIP.

    Measured: First 10 minutes after birth

Secondary outcomes (21)
  1. False negative rate

    Proportion of non-synchronized ventilator breaths with corresponding RIP signal. This will be related to all spontaneous breaths detected by RIP.

    Measured: First 10 minutes after birth

  2. False positive rate

    Proportion of graseby triggered ventilator breaths without corresponding RIP signal. This will be related to all ventilator breaths without a corresponding RIP signal (i.e. movement artefacts).

    Measured: First 10 minutes after birth

  3. Proportion of artifacts

    Proportion of graseby triggered ventilator breaths without corresponding RIP signal. This will be related to all ventilator breaths.

    Measured: First 10 minutes after birth

  4. Specificity (true negative rate)

    Proportion of ventilator breaths without corresponding RIP signal and with no graseby signal (i.e. during an apnoea). This will be related to all ventilator breaths without a corresponding RIP signal.

    Measured: First 10 minutes after birth

  5. Proportion of back up breaths

    Proportion of ventilator breaths without corresponding RIP signal and with no graseby signal. This will be related to all ventilator breaths.

    Measured: First 10 minutes after birth

  6. Proportion of time of synchronised breaths, non-synchronized breaths, periods of apnoea and periods of movement artefacts occure within the first ten minutes of respiratory support.

    Measured: First 10 minutes after birth

  7. Time until the graseby capsule is attached to the infant's abdomen and the proportion of infants in whom the graseby capsule is attached within the first two minutes after birth.

    Measured: First 10 minutes after birth

  8. Proportion of time non invasive ventilator breaths will be applied.

    Measured: First 10 minutes after birth

  9. Peak inspiratory pressure (PIP)

    Measured: First 10 minutes after birth

  10. Positive end expiatory pressure (PEEP)

    Measured: First 10 minutes after birth

  11. Mean airway pressure (MAP)

    Measured: First 10 minutes after birth

  12. Td (time delay) graseby

    Time between the initial increase of the abdominal RIP curve and the initial increase of the graseby curve.

    Measured: First 10 minutes after birth

  13. Td (time delay) ventilator

    Time between the initial increase of the graseby curve and the beginning of the pressure curve.

    Measured: First 10 minutes after birth

  14. Ti ventilator

    Inspiratory time of a ventilator breath

    Measured: First 10 minutes after birth

  15. Ti RIP

    Inspiratory time of a spontaneous breath

    Measured: First 10 minutes after birth

  16. Ti excess

    Calculated: ((Ti ventilator - Ti RIP)/Ti RIP)) x 100

    Measured: First 10 minutes after birth

  17. Swing RIP

    Amplitude of the RIP curve calculated by subtracting the baseline RIP from the peak RIP curve, which is a surrogate parameter for the patient's respiratory effort.

    Measured: First 10 minutes after birth

  18. Number of tactile stimulations and other interventions on the patient

    Number of tactile stimulations and other interventions on the patient (e.g. placement of intravenous line, non-invasive administration of surfactant, intubation, chest compression) are documented by video analysis.

    Measured: First 10 minutes after birth

  19. Heart rate

    Measured: First 10 minutes after birth

  20. Oxygen saturation

    Measured: First 10 minutes after birth

  21. Fraction of inspired oxygen

    Measured: First 10 minutes after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2022
  2. Study start22 Apr 2022
  3. Primary completion11 Oct 2023
  4. Study completion11 Oct 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05399914
Sponsor's protocol ID
310/2021BO1
Acronym
SenSyNoPP
Status last verified
Apr 2022
First submitted
20 Apr 2022
Last updated
23 Sep 2024
Results posted
No
Individual data sharing
Undecided

Publications

  • Warth PP, Ruegger CM, Gaertner VD, Braun W, Molnar K, Brozek J, Poets CF, Springer L. Synchronised Non-Invasive Intermittent Positive Pressure Ventilation in Very Preterm Infants After Birth: A Feasibility Study. Acta Paediatr. 2025 Dec;114(12):3159-3165. doi: 10.1111/apa.70220. Epub 2025 Jul 16.

    PubMed 40665887

Questions about this trial

What is this clinical trial studying?

An observational study of Preterm Infant and Delivery Room, run by University Hospital Tuebingen at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Synchronisation rate (time frame: First 10 minutes after birth). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05399914, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in